Illumina reagent chemistry kits
Ended Awarded Last action
- Contract number
- 75F40126F19061
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $106,974
Award facts
- Contract value 100% obligated
- $106,973.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Laurel, MD, USA
Award details come from SAM.gov/FPDS.
About this award
On March 23, 2026, the Food and Drug Administration awarded a delivery order to Illumina, Inc. for Illumina Reagent Chemistry Kits, with a ceiling value of $106,973.85 and a firm fixed-price contract type. The delivery order is scheduled for ultimate completion by April 30, 2026, with performance taking place in Laurel, Maryland. This award carries no set-aside designation, reflecting Illumina's specialized position as a provider of proprietary genetic sequencing reagents and consumables. The procurement supports FDA laboratory operations and aligns with the agency's mission to ensure the safety and efficacy of food, pharmaceuticals, and medical devices through advanced genomic analysis capabilities.
Illumina, Inc., a San Diego-based biotechnology company, serves as an established federal contractor with extensive experience supplying DNA and RNA sequencing instruments, reagents, and bioinformatics software to civilian and defense agencies. The company maintains a significant $45 million indefinite delivery contract with the U.S. Department of Agriculture through June 2030 and has received numerous awards from agencies including the National Institutes of Health, National Cancer Institute, Department of Veterans Affairs, and Defense Health Agency. This FDA delivery order represents a modest procurement within Illumina's broader portfolio of federal genomic sequencing solutions, supporting critical laboratory diagnostic and research capabilities across the government.
Quick answers
Who was awarded contract 75F40126F19061?
75F40126F19061 was awarded to Illumina, Inc. by Food and Drug Administration (Department of Health and Human Services) on March 23, 2026.
How much is contract 75F40126F19061 worth?
The government has obligated $106,974 on 75F40126F19061.
Is contract 75F40126F19061 an order under another contract?
Yes. 75F40126F19061 is a delivery order under 75F40123D00001, an indefinite delivery contract.
Was contract 75F40126F19061 competed?
The extent of competition for 75F40126F19061 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award